ONTOLOGY REPORT - ANNOTATIONS
| Term: | zinc sulfate |
|
| Accession: | CHEBI:35176
|
browse the term
|
| Definition: | A metal sulfate compound having zinc(2+) as the counterion. |
| Synonyms: | related_synonym: | InChI=1S/H2O4S.Zn/c1-5(2,3)4;/h(H2,1,2,3,4);/q;+2/p-2; InChIKey=NWONKYPBYAMBJT-UHFFFAOYSA-L; O4SZn; ZnSO4; [Zn++].[O-]S([O-])(=O)=O; zinc sulfate (1:1); zinc sulfate anhydrous; zinc sulphate; zinc(2+) sulfate; zinc(II) sulfate |
| | xref_casrn: | 7733-02-0 |
| | xref: | ChEMBL:774880 "ChEMBL COMPOUND"; ChemIDplus:7733-02-0 "CAS Registry Number"; CiteXplore:10469300 "PubMed citation"; CiteXplore:8566016 "PubMed citation"; Gmelin:18165 "Gmelin Registry Number" |
| | xref_mesh: | MESH:D019287 |
| | xref: | Wikipedia:Zinc_Sulfate "Wikipedia" |
|
|
zinc sulfate
|
| G |
Abcc10 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 10 |
|
increases expression |
ISO |
9 |
10,219,822 |
10,239,734 |
RGD:6480464 |
CTD |
| G |
Abcc9 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 9 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcg1 |
ATP-binding cassette, subfamily G (WHITE), member 1 |
|
increases expression |
EXP |
20 |
9,390,485 |
9,459,574 |
RGD:6480464 |
CTD |
| G |
Abhd5 |
abhydrolase domain containing 5 |
|
decreases expression |
ISO |
8 |
122,148,937 |
122,173,147 |
RGD:6480464 |
CTD |
| G |
Acacb |
acetyl-CoA carboxylase beta |
|
increases expression |
EXP |
12 |
43,388,679 |
43,492,993 |
RGD:6480464 |
CTD |
| G |
Acads |
acyl-CoA dehydrogenase, C-2 to C-3 short chain |
|
increases expression |
ISO |
12 |
42,765,284 |
42,774,528 |
RGD:6480464 |
CTD |
| G |
Acadsb |
acyl-CoA dehydrogenase, short/branched chain |
|
increases expression |
EXP |
1 |
190,987,657 |
191,026,275 |
RGD:6480464 |
CTD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
increases expression |
EXP |
10 |
56,856,233 |
56,861,380 |
RGD:6480464 |
CTD |
| G |
Acp5 |
acid phosphatase 5, tartrate resistant |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Acp5 |
acid phosphatase 5, tartrate resistant |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Actc1 |
actin, alpha, cardiac muscle 1 |
|
decreases expression |
EXP |
3 |
99,901,022 |
99,906,558 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
multiple interactions |
ISO |
2 |
235,799,396 |
235,811,584 |
RGD:6480464 |
CTD |
| G |
Adm |
adrenomedullin |
|
increases expression |
ISO |
1 |
168,380,255 |
168,382,426 |
RGD:6480464 |
CTD |
| G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
|
multiple interactions |
ISO |
X |
134,868,878 |
134,908,166 |
RGD:6480464 |
CTD |
| G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
|
increases expression |
ISO |
17 |
77,034,737 |
77,081,406 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Alad |
aminolevulinate dehydratase |
|
multiple interactions |
EXP |
5 |
79,505,645 |
79,515,983 |
RGD:6480464 |
CTD |
| G |
Alad |
aminolevulinate dehydratase |
|
multiple interactions |
EXP |
5 |
79,505,645 |
79,515,983 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
decreases expression |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
multiple interactions |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
|
multiple interactions |
ISO |
10 |
47,365,195 |
47,374,880 |
RGD:6480464 |
CTD |
| G |
Aldob |
aldolase B, fructose-bisphosphate |
|
decreases expression |
ISO |
5 |
66,283,165 |
66,296,171 |
RGD:6480464 |
CTD |
| G |
Angpt4 |
angiopoietin 4 |
|
increases expression |
ISO |
3 |
142,249,115 |
142,282,307 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
decreases expression |
EXP |
8 |
73,897,618 |
73,934,041 |
RGD:6480464 |
CTD |
| G |
Ap2b1 |
adaptor-related protein complex 2, beta 1 subunit |
|
decreases expression |
ISO |
10 |
71,386,233 |
71,488,000 |
RGD:6480464 |
CTD |
| G |
Apbb1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
|
decreases expression |
ISO |
1 |
163,282,918 |
163,299,333 |
RGD:6480464 |
CTD |
| G |
Apc2 |
adenomatosis polyposis coli 2 |
|
decreases expression |
ISO |
7 |
10,903,675 |
10,920,010 |
RGD:6480464 |
CTD |
| G |
Aprt |
adenine phosphoribosyl transferase |
|
decreases expression |
ISO |
19 |
52,854,657 |
52,856,625 |
RGD:6480464 |
CTD |
| G |
Aqp1 |
aquaporin 1 |
|
increases expression |
EXP |
4 |
84,098,346 |
84,110,524 |
RGD:6480464 |
CTD |
| G |
Arhgef18 |
rho/rac guanine nucleotide exchange factor (GEF) 18 |
|
increases expression |
ISO |
12 |
2,712,198 |
2,855,137 |
RGD:6480464 |
CTD |
| G |
Arhgef3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
|
decreases expression |
ISO |
16 |
2,595,636 |
2,665,051 |
RGD:6480464 |
CTD |
| G |
Art1 |
ADP-ribosyltransferase 1 |
|
decreases expression |
EXP |
1 |
159,586,246 |
159,590,797 |
RGD:6480464 |
CTD |
| G |
Art3 |
ADP-ribosyltransferase 3 |
|
increases expression |
EXP |
14 |
17,198,267 |
17,280,642 |
RGD:6480464 |
CTD |
| G |
Atf2 |
activating transcription factor 2 |
|
increases phosphorylation |
ISO |
3 |
56,403,676 |
56,496,473 |
RGD:6480464 |
CTD |
| G |
Atp2c1 |
ATPase, Ca++ transporting, type 2C, member 1 |
|
increases expression |
EXP |
8 |
110,516,092 |
110,603,620 |
RGD:6480464 |
CTD |
| G |
Bag1 |
BCL2-associated athanogene |
|
decreases expression |
ISO |
5 |
58,329,720 |
58,342,293 |
RGD:6480464 |
CTD |
| G |
Baz1b |
bromodomain adjacent to zinc finger domain, 1B |
|
increases expression |
ISO |
12 |
22,586,411 |
22,644,378 |
RGD:6480464 |
CTD |
| G |
Bbc3 |
Bcl-2 binding component 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bbs9 |
Bardet-Biedl syndrome 9 |
|
decreases expression |
ISO |
8 |
22,231,570 |
22,542,713 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
multiple interactions |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
multiple interactions |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
multiple interactions |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Blk |
B lymphoid tyrosine kinase |
|
increases expression |
ISO |
15 |
42,643,847 |
42,682,793 |
RGD:6480464 |
CTD |
| G |
Brd1 |
bromodomain containing 1 |
|
increases expression |
ISO |
7 |
126,987,011 |
127,035,473 |
RGD:6480464 |
CTD |
| G |
Brd8 |
bromodomain containing 8 |
|
increases expression |
ISO |
18 |
27,074,235 |
27,094,586 |
RGD:6480464 |
CTD |
| G |
C3 |
complement component 3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cabp4 |
calcium binding protein 4 |
|
increases expression |
ISO |
1 |
206,718,302 |
206,722,801 |
RGD:6480464 |
CTD |
| G |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
|
increases expression |
EXP |
4 |
154,895,691 |
155,517,389 |
RGD:6480464 |
CTD |
| G |
Cadps |
Ca++-dependent secretion activator |
|
increases expression |
EXP |
15 |
13,859,286 |
14,319,814 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
decreases expression |
EXP |
6 |
124,477,601 |
124,485,669 |
RGD:6480464 |
CTD |
| G |
Calm3 |
calmodulin 3 |
|
decreases expression |
EXP |
1 |
77,245,609 |
77,252,717 |
RGD:6480464 |
CTD |
| G |
Capn10 |
calpain 10 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccdc130 |
coiled-coil domain containing 130 |
|
increases expression |
ISO |
19 |
25,582,029 |
25,589,845 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
decreases expression |
EXP |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
increases expression |
ISO |
8 |
128,892,784 |
128,893,905 |
RGD:6480464 |
CTD |
| G |
Cd22 |
CD22 molecule |
|
increases expression |
ISO |
1 |
85,923,707 |
85,938,567 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
increases expression |
EXP |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd8b |
CD8b molecule |
|
increases expression |
ISO |
4 |
104,536,454 |
104,552,683 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
EXP |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
|
decreases expression |
ISO |
17 |
71,214,906 |
71,218,463 |
RGD:6480464 |
CTD |
| G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
|
multiple interactions |
ISO |
1 |
249,122,845 |
249,158,369 |
RGD:6480464 |
CTD |
| G |
Cib3 |
calcium and integrin binding family member 3 |
|
decreases expression |
ISO |
16 |
18,046,964 |
18,055,850 |
RGD:6480464 |
CTD |
| G |
Clcn7 |
chloride channel, voltage-sensitive 7 |
|
increases expression |
ISO |
10 |
14,379,803 |
14,403,898 |
RGD:6480464 |
CTD |
| G |
Clcnkb |
chloride channel, voltage-sensitive Kb |
|
decreases expression |
ISO |
5 |
160,294,294 |
160,305,991 |
RGD:6480464 |
CTD |
| G |
Cnbp |
CCHC-type zinc finger, nucleic acid binding protein |
|
increases expression |
ISO |
4 |
122,033,037 |
122,041,891 |
RGD:6480464 |
CTD |
| G |
Cnn3 |
calponin 3, acidic |
|
decreases expression |
EXP |
2 |
218,044,803 |
218,075,914 |
RGD:6480464 |
CTD |
| G |
Cntf |
ciliary neurotrophic factor |
|
multiple interactions |
ISO |
1 |
215,842,668 |
215,844,691 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Commd10 |
COMM domain containing 10 |
|
decreases expression |
ISO |
18 |
41,226,869 |
41,362,841 |
RGD:6480464 |
CTD |
| G |
Cox17 |
cytochrome c oxidase assembly homolog 17 (yeast) |
|
decreases expression |
EXP |
11 |
64,183,573 |
64,185,985 |
RGD:6480464 |
CTD |
| G |
Cox8a |
cytochrome c oxidase subunit VIIIa |
|
decreases expression |
EXP |
1 |
209,886,141 |
209,888,462 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
increases expression |
EXP |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Cr1l |
complement component (3b/4b) receptor 1-like |
|
multiple interactions |
ISO |
13 |
111,010,296 |
111,057,427 |
RGD:6480464 |
CTD |
| G |
Cr1l |
complement component (3b/4b) receptor 1-like |
|
increases expression |
ISO |
13 |
111,010,296 |
111,057,427 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
affects expression |
ISO |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases phosphorylation |
ISO |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
ISO |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Cs |
citrate synthase |
|
increases expression |
EXP |
7 |
1,626,181 |
1,652,197 |
RGD:6480464 |
CTD |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
multiple interactions |
ISO |
2 |
203,292,765 |
203,307,968 |
RGD:6480464 |
CTD |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
multiple interactions |
ISO |
2 |
203,292,765 |
203,307,968 |
RGD:6480464 |
CTD |
| G |
Ctsk |
cathepsin K |
|
multiple interactions |
ISO |
2 |
190,394,854 |
190,405,668 |
RGD:6480464 |
CTD |
| G |
Ctsk |
cathepsin K |
|
decreases expression |
ISO |
2 |
190,394,854 |
190,405,668 |
RGD:6480464 |
CTD |
| G |
Ctsk |
cathepsin K |
|
multiple interactions |
ISO |
2 |
190,394,854 |
190,405,668 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
increases expression |
EXP |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
EXP |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
decreases expression |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
increases expression |
ISO |
14 |
18,825,357 |
18,826,269 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
5 |
135,917,327 |
135,934,636 |
RGD:6480464 |
CTD |
| G |
Dcaf8 |
DDB1 and CUL4 associated factor 8 |
|
decreases expression |
ISO |
13 |
88,029,285 |
88,186,506 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
increases expression |
EXP |
20 |
27,252,273 |
27,254,371 |
RGD:6480464 |
CTD |
| G |
Ddx23 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 23 |
|
increases expression |
ISO |
7 |
137,394,834 |
137,412,075 |
RGD:6480464 |
CTD |
| G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
|
increases expression |
EXP |
7 |
114,552,051 |
114,562,423 |
RGD:6480464 |
CTD |
| G |
Dhx58 |
DEXH (Asp-Glu-X-His) box polypeptide 58 |
|
decreases expression |
ISO |
10 |
89,630,145 |
89,641,311 |
RGD:6480464 |
CTD |
| G |
Dicer1 |
dicer 1, ribonuclease type III |
|
increases expression |
ISO |
6 |
128,777,468 |
128,838,780 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
multiple interactions |
EXP |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Dstn |
destrin |
|
decreases expression |
ISO |
3 |
132,358,484 |
132,385,198 |
RGD:6480464 |
CTD |
| G |
Dtx3 |
deltex homolog 3 (Drosophila) |
|
increases expression |
ISO |
7 |
67,145,276 |
67,149,937 |
RGD:6480464 |
CTD |
| G |
Dusp5 |
dual specificity phosphatase 5 |
|
decreases expression |
EXP |
1 |
259,754,234 |
259,767,645 |
RGD:6480464 |
CTD |
| G |
Dync1h1 |
dynein cytoplasmic 1 heavy chain 1 |
|
decreases expression |
ISO |
6 |
135,318,083 |
135,391,459 |
RGD:6480464 |
CTD |
| G |
Dync1li2 |
dynein, cytoplasmic 1 light intermediate chain 2 |
|
increases expression |
ISO |
19 |
469,163 |
510,647 |
RGD:6480464 |
CTD |
| G |
Eda |
ectodysplasin-A |
|
decreases expression |
ISO |
X |
87,982,303 |
88,390,680 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
decreases expression |
EXP |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Eef2k |
eukaryotic elongation factor-2 kinase |
|
increases expression |
EXP |
1 |
179,712,404 |
179,754,345 |
RGD:6480464 |
CTD |
| G |
Efna1 |
ephrin A1 |
|
increases expression |
ISO |
2 |
181,444,599 |
181,451,944 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
EXP |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egfl7 |
EGF-like-domain, multiple 7 |
|
decreases expression |
ISO |
3 |
4,760,574 |
4,769,909 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases phosphorylation |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases phosphorylation |
EXP |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egln1 |
EGL nine homolog 1 (C. elegans) |
|
increases expression |
ISO |
19 |
55,080,670 |
55,118,226 |
RGD:6480464 |
CTD |
| G |
Ehd1 |
EH-domain containing 1 |
|
increases expression |
ISO |
1 |
209,055,234 |
209,077,609 |
RGD:6480464 |
CTD |
| G |
Elk1 |
ELK1, member of ETS oncogene family |
|
multiple interactions |
ISO |
X |
12,597,863 |
12,604,248 |
RGD:6480464 |
CTD |
| G |
Elk1 |
ELK1, member of ETS oncogene family |
|
increases activity |
ISO |
X |
12,597,863 |
12,604,248 |
RGD:6480464 |
CTD |
| G |
Emid1 |
EMI domain containing 1 |
|
increases expression |
ISO |
14 |
85,765,394 |
85,801,932 |
RGD:6480464 |
CTD |
| G |
Epha7 |
Eph receptor A7 |
|
increases expression |
ISO |
5 |
44,728,037 |
44,878,332 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
EXP |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ercc1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 |
|
increases expression |
ISO |
1 |
78,711,249 |
78,722,474 |
RGD:6480464 |
CTD |
| G |
Ergic3 |
ERGIC and golgi 3 |
|
decreases expression |
ISO |
3 |
146,416,599 |
146,426,325 |
RGD:6480464 |
CTD |
| G |
Esd |
esterase D |
|
decreases expression |
ISO |
15 |
55,556,681 |
55,576,172 |
RGD:6480464 |
CTD |
| G |
Exosc7 |
exosome component 7 |
|
decreases expression |
ISO |
8 |
127,868,051 |
127,893,391 |
RGD:6480464 |
CTD |
| G |
Fabp5 |
fatty acid binding protein 5, epidermal |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fads1 |
fatty acid desaturase 1 |
|
decreases expression |
ISO |
1 |
212,670,792 |
212,685,718 |
RGD:6480464 |
CTD |
| G |
Fam13a |
family with sequence similarity 13, member A |
|
decreases expression |
ISO |
4 |
87,832,159 |
87,931,440 |
RGD:6480464 |
CTD |
| G |
Fcer1a |
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide |
|
multiple interactions |
ISO |
13 |
89,429,982 |
89,436,507 |
RGD:6480464 |
CTD |
| G |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
|
decreases expression |
ISO |
8 |
38,078,328 |
38,123,983 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
increases expression |
EXP |
18 |
31,785,480 |
31,806,452 |
RGD:6480464 |
CTD |
| G |
Flt1 |
FMS-related tyrosine kinase 1 |
|
increases expression |
EXP |
12 |
7,858,092 |
8,035,966 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Foxn4 |
forkhead box N4 |
|
increases expression |
ISO |
12 |
43,372,586 |
43,381,544 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
multiple interactions |
ISO |
2 |
141,127,345 |
141,203,446 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
increases phosphorylation |
ISO |
2 |
141,127,345 |
141,203,446 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
affects localization |
ISO |
2 |
141,127,345 |
141,203,446 |
RGD:6480464 |
CTD |
| G |
Foxo3 |
forkhead box O3 |
|
increases expression |
ISO |
20 |
46,171,784 |
46,262,818 |
RGD:6480464 |
CTD |
| G |
Foxo4 |
forkhead box O4 |
|
multiple interactions |
ISO |
X |
89,332,278 |
89,338,835 |
RGD:6480464 |
CTD |
| G |
Foxo4 |
forkhead box O4 |
|
increases phosphorylation |
ISO |
X |
89,332,278 |
89,338,835 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
multiple interactions |
ISO |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
increases expression |
ISO |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
decreases expression |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gata4 |
GATA binding protein 4 |
|
decreases expression |
EXP |
15 |
42,472,793 |
42,519,569 |
RGD:6480464 |
CTD |
| G |
Gata6 |
GATA binding protein 6 |
|
increases expression |
EXP |
18 |
2,504,264 |
2,534,648 |
RGD:6480464 |
CTD |
| G |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
|
increases expression |
EXP |
1 |
220,824,976 |
220,829,980 |
RGD:6480464 |
CTD |
| G |
Gdnf |
glial cell derived neurotrophic factor |
|
decreases expression |
ISO |
2 |
57,399,312 |
57,424,030 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
multiple interactions |
EXP |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Ghr |
growth hormone receptor |
|
decreases expression |
EXP |
2 |
52,496,517 |
52,658,066 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Glul |
glutamate-ammonia ligase |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gnas |
GNAS complex locus |
|
decreases activity |
EXP |
3 |
165,213,399 |
165,214,551 |
RGD:6480464 |
CTD |
| G |
Gnb2l1 |
guanine nucleotide binding protein (G protein), beta polypeptide 2 like 1 |
|
decreases expression |
ISO |
10 |
34,067,237 |
34,072,593 |
RGD:6480464 |
CTD |
| G |
Gng11 |
guanine nucleotide binding protein (G protein), gamma 11 |
|
decreases expression |
ISO |
4 |
28,847,907 |
28,853,347 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Grk1 |
G protein-coupled receptor kinase 1 |
|
multiple interactions |
EXP |
16 |
80,979,323 |
80,991,796 |
RGD:6480464 |
CTD |
| G |
Grk1 |
G protein-coupled receptor kinase 1 |
|
decreases expression |
EXP |
16 |
80,979,323 |
80,991,796 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
multiple interactions |
EXP |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
increases expression |
EXP |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
H2afv |
H2A histone family, member V |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
multiple interactions |
ISO |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hilpda |
hypoxia inducible lipid droplet-associated |
|
increases expression |
ISO |
4 |
56,146,654 |
56,147,441 |
RGD:6480464 |
CTD |
| G |
Hist1h2bk |
histone cluster 1, H2bk |
|
decreases expression |
ISO |
17 |
50,118,776 |
50,119,156 |
RGD:6480464 |
CTD |
| G |
Hk1 |
hexokinase 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
decreases expression |
EXP |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
increases expression |
ISO |
2 |
193,128,736 |
193,143,106 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hoxd1 |
homeo box D1 |
|
decreases expression |
ISO |
3 |
57,377,839 |
57,379,978 |
RGD:6480464 |
CTD |
| G |
Hrh4 |
histamine receptor H4 |
|
decreases expression |
ISO |
18 |
4,275,671 |
4,292,259 |
RGD:6480464 |
CTD |
| G |
Hs2st1 |
heparan sulfate 2-O-sulfotransferase 1 |
|
decreases expression |
ISO |
2 |
242,622,270 |
242,760,095 |
RGD:6480464 |
CTD |
| G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
|
decreases expression |
ISO |
13 |
109,063,491 |
109,089,468 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock transcription factor 1 |
|
multiple interactions |
ISO |
7 |
114,524,211 |
114,551,166 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock transcription factor 1 |
|
multiple interactions |
ISO |
7 |
114,524,211 |
114,551,166 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock transcription factor 1 |
|
increases activity |
ISO |
7 |
114,524,211 |
114,551,166 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock transcription factor 1 |
|
increases activity |
ISO |
7 |
114,524,211 |
114,551,166 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
decreases expression |
EXP |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
affects localization |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
multiple interactions |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
multiple interactions |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
multiple interactions |
EXP |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
EXP |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
increases expression |
EXP |
20 |
3,955,274 |
3,957,748 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
increases expression |
ISO |
20 |
3,955,274 |
3,957,748 |
RGD:6480464 |
CTD |
| G |
Hspa1l |
heat shock protein 1-like |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hspa4 |
heat shock protein 4 |
|
decreases expression |
ISO |
10 |
38,705,629 |
38,749,058 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
affects localization |
ISO |
8 |
43,784,035 |
43,787,760 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Idh1 |
isocitrate dehydrogenase 1 (NADP+), soluble |
|
increases expression |
EXP |
9 |
63,769,401 |
63,790,622 |
RGD:6480464 |
CTD |
| G |
Ifi27 |
interferon, alpha-inducible protein 27 |
|
decreases expression |
ISO |
6 |
127,725,194 |
127,731,665 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifngr1 |
interferon gamma receptor 1 |
|
increases expression |
ISO |
1 |
14,846,369 |
14,864,804 |
RGD:6480464 |
CTD |
| G |
Ift57 |
intraflagellar transport 57 homolog (Chlamydomonas) |
|
increases expression |
ISO |
11 |
52,251,655 |
52,321,489 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
multiple interactions |
ISO |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
decreases expression |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases secretion |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
increases expression |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il23r |
interleukin 23 receptor |
|
decreases expression |
ISO |
4 |
97,087,580 |
97,768,978 |
RGD:6480464 |
CTD |
| G |
Il24 |
interleukin 24 |
|
decreases expression |
ISO |
13 |
43,831,510 |
43,836,908 |
RGD:6480464 |
CTD |
| G |
Il4r |
interleukin 4 receptor |
|
increases expression |
ISO |
1 |
184,612,903 |
184,637,863 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6st |
interleukin 6 signal transducer |
|
multiple interactions |
ISO |
2 |
43,806,301 |
43,842,365 |
RGD:6480464 |
CTD |
| G |
Il6st |
interleukin 6 signal transducer |
|
decreases expression |
ISO |
2 |
43,806,301 |
43,842,365 |
RGD:6480464 |
CTD |
| G |
Jph3 |
junctophilin 3 |
|
increases expression |
ISO |
19 |
51,975,477 |
52,037,634 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases activity |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases phosphorylation |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kat8 |
K (lysine) acetyltransferase 8 |
|
increases expression |
ISO |
1 |
187,198,682 |
187,210,962 |
RGD:6480464 |
CTD |
| G |
Kazn |
kazrin, periplakin interacting protein |
|
increases expression |
ISO |
5 |
161,041,203 |
161,399,651 |
RGD:6480464 |
CTD |
| G |
Kcnj5 |
potassium inwardly-rectifying channel, subfamily J, member 5 |
|
increases expression |
EXP |
8 |
32,082,866 |
32,104,412 |
RGD:6480464 |
CTD |
| G |
Kcnj8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
|
increases expression |
EXP |
4 |
180,144,084 |
180,149,935 |
RGD:6480464 |
CTD |
| G |
Kcnq1 |
potassium voltage-gated channel, KQT-like subfamily, member 1 |
|
increases expression |
EXP |
1 |
203,383,401 |
203,803,687 |
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Klf15 |
Kruppel-like factor 15 |
|
increases expression |
EXP |
4 |
124,714,395 |
124,726,991 |
RGD:6480464 |
CTD |
| G |
Klf9 |
Kruppel-like factor 9 |
|
increases expression |
EXP |
1 |
226,420,949 |
226,446,376 |
RGD:6480464 |
CTD |
| G |
Klk8 |
kallikrein related-peptidase 8 |
|
decreases activity |
ISO |
1 |
94,227,185 |
94,234,028 |
RGD:6480464 |
CTD |
| G |
Lama4 |
laminin, alpha 4 |
|
decreases expression |
ISO |
20 |
43,077,612 |
43,203,519 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
decreases expression |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lilra5 |
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 |
|
decreases expression |
ISO |
1 |
69,383,580 |
69,388,145 |
RGD:6480464 |
CTD |
| G |
LOC500956 |
hypothetical protein LOC500956 |
|
decreases expression |
ISO |
8 |
19,893,861 |
19,899,475 |
RGD:6480464 |
CTD |
| G |
Lpin2 |
lipin 2 |
|
decreases expression |
ISO |
9 |
110,380,692 |
110,484,329 |
RGD:6480464 |
CTD |
| G |
Lppr1 |
lipid phosphate phosphatase-related protein type 1 |
|
decreases expression |
ISO |
5 |
65,982,029 |
66,115,218 |
RGD:6480464 |
CTD |
| G |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
|
increases expression |
ISO |
4 |
127,975,386 |
128,597,119 |
RGD:6480464 |
CTD |
| G |
Mal |
mal, T-cell differentiation protein |
|
increases expression |
ISO |
3 |
115,166,671 |
115,190,432 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
multiple interactions |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
multiple interactions |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
increases phosphorylation |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
multiple interactions |
ISO |
7 |
10,074,654 |
10,094,003 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
multiple interactions |
ISO |
7 |
10,074,654 |
10,094,003 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
increases phosphorylation |
ISO |
7 |
10,074,654 |
10,094,003 |
RGD:6480464 |
CTD |
| G |
Map3k1 |
mitogen activated protein kinase kinase kinase 1 |
|
decreases expression |
EXP |
2 |
43,062,252 |
43,126,058 |
RGD:6480464 |
CTD |
| G |
Map3k13 |
mitogen-activated protein kinase kinase kinase 13 |
|
decreases expression |
ISO |
11 |
81,327,515 |
81,467,415 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk7 |
mitogen-activated protein kinase 7 |
|
increases expression |
ISO |
10 |
47,649,203 |
47,654,316 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases phosphorylation |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mbnl2 |
muscleblind-like splicing regulator 2 |
|
decreases expression |
ISO |
15 |
105,356,456 |
105,514,135 |
RGD:6480464 |
CTD |
| G |
Mllt4 |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 |
|
increases expression |
ISO |
1 |
48,827,687 |
48,913,175 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mog |
myelin oligodendrocyte glycoprotein |
|
decreases expression |
ISO |
20 |
1,601,731 |
1,611,963 |
RGD:6480464 |
CTD |
| G |
Mphosph6 |
M phase phosphoprotein 6 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mphosph6-ps1 |
M phase phosphoprotein 6, pseudogene |
|
decreases expression |
ISO |
6 |
103,512,896 |
103,513,378 |
RGD:6480464 |
CTD |
| G |
Mpst |
mercaptopyruvate sulfurtransferase |
|
decreases expression |
EXP |
7 |
116,359,466 |
116,364,146 |
RGD:6480464 |
CTD |
| G |
Mras |
muscle RAS oncogene homolog |
|
multiple interactions |
ISO |
8 |
104,244,660 |
104,272,556 |
RGD:6480464 |
CTD |
| G |
Mras |
muscle RAS oncogene homolog |
|
increases activity |
ISO |
8 |
104,244,660 |
104,272,556 |
RGD:6480464 |
CTD |
| G |
Mrpl12 |
mitochondrial ribosomal protein L12 |
|
increases expression |
ISO |
10 |
109,870,160 |
109,874,664 |
RGD:6480464 |
CTD |
| G |
Mst1 |
Macrophage stimulating 1 (hepatocyte growth factor-like) |
|
decreases expression |
ISO |
8 |
113,348,203 |
113,352,773 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
decreases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
decreases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
EXP |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
EXP |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
EXP |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
EXP |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal-regulatory transcription factor 1 |
|
multiple interactions |
ISO |
5 |
144,135,674 |
144,180,430 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal-regulatory transcription factor 1 |
|
multiple interactions |
ISO |
5 |
144,135,674 |
144,180,430 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal-regulatory transcription factor 1 |
|
increases activity |
ISO |
5 |
144,135,674 |
144,180,430 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal-regulatory transcription factor 1 |
|
increases expression |
ISO |
5 |
144,135,674 |
144,180,430 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal-regulatory transcription factor 1 |
|
multiple interactions |
ISO |
5 |
144,135,674 |
144,180,430 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal-regulatory transcription factor 1 |
|
increases expression |
ISO |
5 |
144,135,674 |
144,180,430 |
RGD:6480464 |
CTD |
| G |
Mthfd1 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase |
|
decreases expression |
ISO |
6 |
98,849,446 |
98,916,936 |
RGD:6480464 |
CTD |
| G |
Mtus1 |
microtubule associated tumor suppressor 1 |
|
increases expression |
EXP |
16 |
54,611,502 |
54,664,075 |
RGD:6480464 |
CTD |
| G |
Myef2 |
myelin expression factor 2 |
|
increases expression |
ISO |
3 |
112,386,454 |
112,422,182 |
RGD:6480464 |
CTD |
| G |
Myh7 |
myosin, heavy chain 7, cardiac muscle, beta |
|
increases expression |
EXP |
15 |
33,072,928 |
33,094,595 |
RGD:6480464 |
CTD |
| G |
Nab2 |
Ngfi-A binding protein 2 |
|
increases expression |
ISO |
7 |
67,642,321 |
67,648,713 |
RGD:6480464 |
CTD |
| G |
Ncln |
nicalin |
|
increases expression |
ISO |
7 |
9,695,951 |
9,705,989 |
RGD:6480464 |
CTD |
| G |
Necab2 |
N-terminal EF-hand calcium binding protein 2 |
|
increases expression |
ISO |
19 |
49,691,466 |
49,718,718 |
RGD:6480464 |
CTD |
| G |
Nedd4 |
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
8 |
77,252,500 |
77,337,402 |
RGD:6480464 |
CTD |
| G |
Nedd4 |
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
|
multiple interactions |
EXP |
8 |
77,252,500 |
77,337,402 |
RGD:6480464 |
CTD |
| G |
Nedd4 |
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
|
increases expression |
EXP |
8 |
77,252,500 |
77,337,402 |
RGD:6480464 |
CTD |
| G |
Nefm |
neurofilament, medium polypeptide |
|
increases expression |
ISO |
15 |
47,698,371 |
47,703,350 |
RGD:6480464 |
CTD |
| G |
Nfatc1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
|
multiple interactions |
ISO |
18 |
77,498,654 |
77,581,231 |
RGD:6480464 |
CTD |
| G |
Nfatc1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
|
multiple interactions |
ISO |
18 |
77,498,654 |
77,581,231 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
affects expression |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbib |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
|
decreases expression |
ISO |
1 |
83,865,440 |
83,873,010 |
RGD:6480464 |
CTD |
| G |
Npas2 |
neuronal PAS domain protein 2 |
|
decreases expression |
ISO |
9 |
38,255,362 |
38,434,352 |
RGD:6480464 |
CTD |
| G |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Nrg1 |
neuregulin 1 |
|
multiple interactions |
EXP |
16 |
63,937,796 |
64,126,183 |
RGD:6480464 |
CTD |
| G |
Nsmaf |
neutral sphingomyelinase (N-SMase) activation associated factor |
|
increases expression |
ISO |
5 |
19,850,388 |
19,896,839 |
RGD:6480464 |
CTD |
| G |
Ocln |
occludin |
|
multiple interactions |
ISO |
2 |
31,317,090 |
31,367,485 |
RGD:6480464 |
CTD |
| G |
Ogt |
O-linked N-acetylglucosamine (GlcNAc) transferase |
|
increases expression |
ISO |
X |
89,721,369 |
89,766,218 |
RGD:6480464 |
CTD |
| G |
Pabpn1 |
poly(A) binding protein, nuclear 1 |
|
multiple interactions |
ISO |
15 |
32,994,493 |
32,999,104 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
decreases expression |
EXP |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pcdhb20 |
protocadherin beta 20 |
|
increases expression |
ISO |
18 |
30,316,122 |
30,319,497 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pde8a |
phosphodiesterase 8A |
|
decreases expression |
ISO |
1 |
137,415,852 |
137,544,337 |
RGD:6480464 |
CTD |
| G |
Pdia6 |
protein disulfide isomerase family A, member 6 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Pdk2 |
pyruvate dehydrogenase kinase, isozyme 2 |
|
increases expression |
EXP |
10 |
83,710,448 |
83,724,973 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
increases expression |
EXP |
4 |
30,235,296 |
30,245,298 |
RGD:6480464 |
CTD |
| G |
Pdlim7 |
PDZ and LIM domain 7 |
|
decreases expression |
ISO |
17 |
15,168,835 |
15,183,983 |
RGD:6480464 |
CTD |
| G |
Pdp1 |
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
|
increases expression |
EXP |
5 |
26,234,414 |
26,240,301 |
RGD:6480464 |
CTD |
| G |
Pdp2 |
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
|
decreases expression |
EXP |
19 |
307,961 |
312,004 |
RGD:6480464 |
CTD |
| G |
Pfkfb2 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
|
decreases expression |
EXP |
13 |
43,624,838 |
43,652,660 |
RGD:6480464 |
CTD |
| G |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
|
increases expression |
ISO |
17 |
78,241,182 |
78,268,272 |
RGD:6480464 |
CTD |
| G |
Pfkl |
phosphofructokinase, liver |
|
decreases expression |
EXP |
20 |
11,009,359 |
11,032,511 |
RGD:6480464 |
CTD |
| G |
Pfkm |
phosphofructokinase, muscle |
|
decreases expression |
ISO |
7 |
136,826,122 |
136,846,040 |
RGD:6480464 |
CTD |
| G |
Pgap2 |
post-GPI attachment to proteins 2 |
|
decreases expression |
ISO |
1 |
159,696,924 |
159,722,582 |
RGD:6480464 |
CTD |
| G |
Pgk1 |
phosphoglycerate kinase 1 |
|
increases expression |
ISO |
X |
94,324,219 |
94,340,193 |
RGD:6480464 |
CTD |
| G |
Phf7 |
PHD finger protein 7 |
|
decreases expression |
ISO |
16 |
6,671,312 |
6,684,015 |
RGD:6480464 |
CTD |
| G |
Pim3 |
pim-3 oncogene |
|
increases expression |
EXP |
7 |
127,167,984 |
127,172,018 |
RGD:6480464 |
CTD |
| G |
Pkia |
protein kinase (cAMP-dependent, catalytic) inhibitor alpha |
|
increases expression |
EXP |
2 |
96,524,399 |
96,548,144 |
RGD:6480464 |
CTD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
increases expression |
EXP |
13 |
64,135,729 |
64,280,815 |
RGD:6480464 |
CTD |
| G |
Plch1 |
phospholipase C, eta 1 |
|
decreases expression |
ISO |
2 |
153,467,156 |
153,562,651 |
RGD:6480464 |
CTD |
| G |
Pnma2 |
paraneoplastic Ma antigen 2 |
|
decreases expression |
ISO |
15 |
46,452,913 |
46,460,573 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
increases expression |
EXP |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Pou4f2 |
POU class 4 homeobox 2 |
|
decreases expression |
ISO |
19 |
31,388,907 |
31,392,548 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppm1b |
protein phosphatase, Mg2+/Mn2+ dependent, 1B |
|
decreases expression |
EXP |
6 |
8,319,544 |
8,373,795 |
RGD:6480464 |
CTD |
| G |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
|
increases expression |
ISO |
1 |
240,991,884 |
240,996,887 |
RGD:6480464 |
CTD |
| G |
Ppp2r2d |
protein phosphatase 2, regulatory subunit B, delta |
|
increases expression |
ISO |
1 |
198,640,771 |
198,674,758 |
RGD:6480464 |
CTD |
| G |
Prpsap2 |
phosphoribosyl pyrophosphate synthetase-associated protein 2 |
|
increases expression |
EXP |
10 |
47,890,667 |
47,925,430 |
RGD:6480464 |
CTD |
| G |
Prr3 |
proline rich 3 |
|
increases expression |
ISO |
20 |
2,941,531 |
2,946,286 |
RGD:6480464 |
CTD |
| G |
Psmb2 |
proteasome (prosome, macropain) subunit, beta type 2 |
|
decreases expression |
ISO |
5 |
146,089,234 |
146,121,978 |
RGD:6480464 |
CTD |
| G |
Psmc5 |
proteasome (prosome, macropain) 26S subunit, ATPase, 5 |
|
decreases expression |
ISO |
10 |
95,650,987 |
95,656,921 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
multiple interactions |
ISO |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
decreases expression |
ISO |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
increases response to substance |
EXP |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
multiple interactions |
EXP |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
increases ubiquitination |
EXP |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Ptges2 |
prostaglandin E synthase 2 |
|
increases expression |
ISO |
3 |
11,521,214 |
11,528,395 |
RGD:6480464 |
CTD |
| G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
|
decreases activity |
ISO |
3 |
159,070,473 |
159,116,792 |
RGD:6480464 |
CTD |
| G |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
|
increases expression |
EXP |
5 |
94,069,724 |
94,286,657 |
RGD:6480464 |
CTD |
| G |
Ptprn |
protein tyrosine phosphatase, receptor type, N |
|
increases expression |
ISO |
9 |
74,528,095 |
74,542,756 |
RGD:6480464 |
CTD |
| G |
Pts |
6-pyruvoyl-tetrahydropterin synthase |
|
decreases expression |
ISO |
8 |
53,880,701 |
53,887,711 |
RGD:6480464 |
CTD |
| G |
Pxk |
PX domain containing serine/threonine kinase |
|
increases expression |
EXP |
15 |
18,744,748 |
18,815,195 |
RGD:6480464 |
CTD |
| G |
Rab20 |
RAB20, member RAS oncogene family |
|
increases expression |
ISO |
16 |
82,871,002 |
82,895,146 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
decreases expression |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases activity |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Repin1 |
replication initiator 1 |
|
increases expression |
ISO |
4 |
76,688,429 |
76,690,141 |
RGD:6480464 |
CTD |
| G |
RGD1306063 |
similar to HT021 |
|
decreases expression |
ISO |
15 |
14,395,450 |
14,412,116 |
RGD:6480464 |
CTD |
| G |
RGD1560108 |
similar to RIKEN cDNA 2700081O15 |
|
increases expression |
ISO |
1 |
210,104,665 |
210,109,541 |
RGD:6480464 |
CTD |
| G |
Rgn |
regucalcin (senescence marker protein-30) |
|
multiple interactions |
ISO |
X |
13,037,171 |
13,052,846 |
RGD:6480464 |
CTD |
| G |
Rgn |
regucalcin (senescence marker protein-30) |
|
increases expression |
ISO |
X |
13,037,171 |
13,052,846 |
RGD:6480464 |
CTD |
| G |
Rgp1 |
RGP1 retrograde golgi transport homolog (S. cerevisiae) |
|
increases expression |
ISO |
5 |
60,057,647 |
60,061,853 |
RGD:6480464 |
CTD |
| G |
Rgs19 |
regulator of G-protein signaling 19 |
|
decreases expression |
EXP |
3 |
170,839,907 |
170,844,746 |
RGD:6480464 |
CTD |
| G |
Rims2 |
regulating synaptic membrane exocytosis 2 |
|
decreases expression |
ISO |
7 |
74,757,003 |
75,271,771 |
RGD:6480464 |
CTD |
| G |
Ror1 |
receptor tyrosine kinase-like orphan receptor 1 |
|
decreases expression |
ISO |
5 |
120,746,419 |
121,098,205 |
RGD:6480464 |
CTD |
| G |
Rps6ka2 |
ribosomal protein S6 kinase polypeptide 2 |
|
increases expression |
ISO |
1 |
47,424,106 |
47,560,373 |
RGD:6480464 |
CTD |
| G |
Rps6ka6 |
ribosomal protein S6 kinase polypeptide 6 |
|
increases expression |
ISO |
X |
99,798,274 |
99,901,585 |
RGD:6480464 |
CTD |
| G |
Rrh |
retinal pigment epithelium derived rhodopsin homolog |
|
increases expression |
ISO |
2 |
227,256,627 |
227,266,897 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
multiple interactions |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
increases expression |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Sag |
S-antigen; retina and pineal gland (arrestin) |
|
decreases expression |
ISO |
9 |
86,759,933 |
86,799,902 |
RGD:6480464 |
CTD |
| G |
Scg3 |
secretogranin III |
|
increases expression |
ISO |
8 |
80,467,921 |
80,514,192 |
RGD:6480464 |
CTD |
| G |
Scn1a |
sodium channel, voltage-gated, type I, alpha |
|
increases expression |
EXP |
3 |
48,238,528 |
48,364,143 |
RGD:6480464 |
CTD |
| G |
Sema6b |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Sept11 |
septin 11 |
|
decreases expression |
ISO |
14 |
16,465,348 |
16,501,284 |
RGD:6480464 |
CTD |
| G |
Sept8 |
septin 8 |
|
decreases expression |
ISO |
10 |
38,988,030 |
39,011,730 |
RGD:6480464 |
CTD |
| G |
Serinc1 |
serine incorporator 1 |
|
decreases expression |
ISO |
20 |
36,541,193 |
36,560,101 |
RGD:6480464 |
CTD |
| G |
Sertad4 |
SERTA domain containing 4 |
|
increases expression |
ISO |
13 |
108,739,942 |
108,750,295 |
RGD:6480464 |
CTD |
| G |
Sesn2 |
sestrin 2 |
|
multiple interactions |
ISO |
5 |
152,639,951 |
152,655,828 |
RGD:6480464 |
CTD |
| G |
Sesn3 |
sestrin 3 |
|
decreases expression |
ISO |
8 |
11,076,055 |
11,125,523 |
RGD:6480464 |
CTD |
| G |
Sidt2 |
SID1 transmembrane family, member 2 |
|
increases expression |
ISO |
8 |
48,909,652 |
48,925,969 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression |
ISO |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression |
ISO |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
multiple interactions |
ISO |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc12a9 |
solute carrier family 12 (potassium/chloride transporters), member 9 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
multiple interactions |
EXP |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
decreases expression |
EXP |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc20a1 |
solute carrier family 20 (phosphate transporter), member 1 |
|
decreases expression |
EXP |
3 |
116,813,990 |
116,828,049 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
multiple interactions |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
multiple interactions |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
decreases expression |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
EXP |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
affects localization |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
decreases expression |
EXP |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
EXP |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
EXP |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
multiple interactions |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a2 |
solute carrier family 30 (zinc transporter), member 2 |
|
increases expression |
EXP |
5 |
153,086,346 |
153,098,569 |
RGD:6480464 |
CTD |
| G |
Slc30a2 |
solute carrier family 30 (zinc transporter), member 2 |
|
affects localization |
ISO |
5 |
153,086,346 |
153,098,569 |
RGD:6480464 |
CTD |
| G |
Slc30a2 |
solute carrier family 30 (zinc transporter), member 2 |
|
increases expression |
ISO |
5 |
153,086,346 |
153,098,569 |
RGD:6480464 |
CTD |
| G |
Slc30a2 |
solute carrier family 30 (zinc transporter), member 2 |
|
decreases expression |
EXP |
5 |
153,086,346 |
153,098,569 |
RGD:6480464 |
CTD |
| G |
Slc30a2 |
solute carrier family 30 (zinc transporter), member 2 |
|
increases expression |
EXP |
5 |
153,086,346 |
153,098,569 |
RGD:6480464 |
CTD |
| G |
Slc30a4 |
solute carrier family 30 (zinc transporter), member 4 |
|
affects localization |
ISO |
3 |
109,643,714 |
109,665,750 |
RGD:6480464 |
CTD |
| G |
Slc30a4 |
solute carrier family 30 (zinc transporter), member 4 |
|
decreases expression |
EXP |
3 |
109,643,714 |
109,665,750 |
RGD:6480464 |
CTD |
| G |
Slc39a1 |
solute carrier family 39 (zinc transporter), member 1 |
|
decreases expression |
ISO |
2 |
182,490,501 |
182,496,068 |
RGD:6480464 |
CTD |
| G |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
|
decreases expression |
EXP |
9 |
52,168,107 |
52,217,677 |
RGD:6480464 |
CTD |
| G |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
|
increases expression |
EXP |
9 |
52,168,107 |
52,217,677 |
RGD:6480464 |
CTD |
| G |
Slc39a3 |
solute carrier family 39 (zinc transporter), member 3 |
|
affects localization |
ISO |
7 |
10,160,746 |
10,166,609 |
RGD:6480464 |
CTD |
| G |
Slc39a3 |
solute carrier family 39 (zinc transporter), member 3 |
|
decreases expression |
ISO |
7 |
10,160,746 |
10,166,609 |
RGD:6480464 |
CTD |
| G |
Slc6a2 |
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
|
increases expression |
ISO |
19 |
15,098,281 |
15,139,898 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
increases expression |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc9a6 |
solute carrier family 9, subfamily A (NHE6, cation proton antiporter 6), member 6 |
|
increases expression |
ISO |
X |
141,146,237 |
141,201,234 |
RGD:6480464 |
CTD |
| G |
Slco1c1 |
solute carrier organic anion transporter family, member 1c1 |
|
increases expression |
ISO |
4 |
178,959,893 |
179,006,727 |
RGD:6480464 |
CTD |
| G |
Snrk |
SNF related kinase |
|
decreases expression |
ISO |
8 |
121,958,351 |
121,968,989 |
RGD:6480464 |
CTD |
| G |
Snrnp70 |
small nuclear ribonucleoprotein 70 (U1) |
|
decreases degradation |
ISO |
1 |
95,853,923 |
95,868,393 |
RGD:6480464 |
CTD |
| G |
Socs2 |
suppressor of cytokine signaling 2 |
|
increases expression |
ISO |
7 |
32,605,714 |
32,608,323 |
RGD:6480464 |
CTD |
| G |
Sord |
sorbitol dehydrogenase |
|
decreases expression |
ISO |
3 |
109,016,830 |
109,048,446 |
RGD:6480464 |
CTD |
| G |
Spg7 |
spastic paraplegia 7 homolog (human) |
|
increases expression |
ISO |
19 |
53,400,904 |
53,433,742 |
RGD:6480464 |
CTD |
| G |
Sptbn1 |
spectrin, beta, non-erythrocytic 1 |
|
decreases expression |
ISO |
14 |
111,076,741 |
111,246,286 |
RGD:6480464 |
CTD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
decreases activity |
ISO |
3 |
148,157,256 |
148,170,524 |
RGD:6480464 |
CTD |
| G |
Srsf5 |
serine/arginine-rich splicing factor 5 |
|
decreases expression |
ISO |
6 |
104,728,286 |
104,732,982 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
multiple interactions |
ISO |
9 |
46,455,635 |
46,497,560 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
increases expression |
ISO |
9 |
46,455,635 |
46,497,560 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Steap4 |
STEAP family member 4 |
|
decreases expression |
ISO |
4 |
22,688,597 |
22,711,432 |
RGD:6480464 |
CTD |
| G |
Sulf1 |
sulfatase 1 |
|
increases expression |
EXP |
5 |
5,582,896 |
5,748,106 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
increases expression |
EXP |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Synrg |
synergin, gamma |
|
increases expression |
ISO |
10 |
72,247,720 |
72,330,036 |
RGD:6480464 |
CTD |
| G |
Tas1r3 |
taste receptor, type 1, member 3 |
|
affects response to substance |
ISO |
5 |
172,718,551 |
172,721,704 |
RGD:6480464 |
CTD |
| G |
Tas2r144 |
taste receptor, type 2, member 144 |
|
increases expression |
ISO |
4 |
69,966,964 |
69,967,923 |
RGD:6480464 |
CTD |
| G |
Tbc1d8 |
TBC1 domain family, member 8 |
|
increases expression |
ISO |
9 |
38,443,425 |
38,554,183 |
RGD:6480464 |
CTD |
| G |
Tbx3 |
T-box 3 |
|
decreases expression |
ISO |
12 |
38,155,494 |
38,166,670 |
RGD:6480464 |
CTD |
| G |
Tbxa2r |
thromboxane A2 receptor |
|
decreases expression |
ISO |
7 |
9,867,739 |
9,872,536 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Thbd |
thrombomodulin |
|
decreases expression |
EXP |
3 |
137,158,955 |
137,162,607 |
RGD:6480464 |
CTD |
| G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
increases expression |
EXP |
7 |
19,677,144 |
19,727,072 |
RGD:6480464 |
CTD |
| G |
Tll1 |
tolloid-like 1 |
|
decreases expression |
ISO |
16 |
28,433,106 |
28,641,870 |
RGD:6480464 |
CTD |
| G |
Tll2 |
tolloid-like 2 |
|
increases expression |
ISO |
1 |
246,259,524 |
246,406,825 |
RGD:6480464 |
CTD |
| G |
Tmem184c |
transmembrane protein 184C |
|
decreases expression |
ISO |
19 |
32,158,361 |
32,174,009 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
affects expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
multiple interactions |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
increases expression |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
multiple interactions |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
multiple interactions |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
| G |
Tns3 |
tensin 3 |
|
increases expression |
ISO |
14 |
88,999,003 |
89,182,348 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tpm4 |
tropomyosin 4 |
|
decreases expression |
EXP |
16 |
18,108,914 |
18,122,956 |
RGD:6480464 |
CTD |
| G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
|
decreases expression |
ISO |
9 |
8,175,081 |
8,186,142 |
RGD:6480464 |
CTD |
| G |
Trim31 |
tripartite motif-containing 31 |
|
decreases expression |
ISO |
20 |
1,745,437 |
1,758,194 |
RGD:6480464 |
CTD |
| G |
Trove2 |
TROVE domain family, member 2 |
|
decreases expression |
ISO |
13 |
57,584,656 |
57,605,648 |
RGD:6480464 |
CTD |
| G |
Trpm5 |
transient receptor potential cation channel, subfamily M, member 5 |
|
affects response to substance |
ISO |
1 |
203,347,410 |
203,364,520 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
increases activity |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Tsr1 |
TSR1, 20S rRNA accumulation, homolog (S. cerevisiae) |
|
increases expression |
ISO |
10 |
62,207,449 |
62,218,861 |
RGD:6480464 |
CTD |
| G |
Txndc12 |
thioredoxin domain containing 12 (endoplasmic reticulum) |
|
decreases expression |
ISO |
5 |
130,142,600 |
130,167,629 |
RGD:6480464 |
CTD |
| G |
Ube2g2 |
ubiquitin-conjugating enzyme E2G 2 |
|
decreases expression |
ISO |
20 |
11,367,545 |
11,389,283 |
RGD:6480464 |
CTD |
| G |
Ube2i |
ubiquitin-conjugating enzyme E2I |
|
increases expression |
ISO |
10 |
14,509,948 |
14,524,551 |
RGD:6480464 |
CTD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
increases expression |
EXP |
1 |
157,896,001 |
157,909,608 |
RGD:6480464 |
CTD |
| G |
Ugcg |
UDP-glucose ceramide glucosyltransferase |
|
increases expression |
ISO |
5 |
77,263,334 |
77,295,794 |
RGD:6480464 |
CTD |
| G |
Unc119 |
UNC-119 homolog (C. elegans) |
|
increases expression |
ISO |
10 |
64,285,993 |
64,291,392 |
RGD:6480464 |
CTD |
| G |
Usp44 |
ubiquitin specific peptidase 44 |
|
decreases expression |
ISO |
7 |
30,898,472 |
30,971,342 |
RGD:6480464 |
CTD |
| G |
Vdac1 |
voltage-dependent anion channel 1 |
|
multiple interactions |
EXP |
10 |
37,795,721 |
37,823,253 |
RGD:6480464 |
CTD |
| G |
Vdac2 |
voltage-dependent anion channel 2 |
|
multiple interactions |
EXP |
15 |
2,515,297 |
2,528,969 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfc |
vascular endothelial growth factor C |
|
decreases expression |
EXP |
16 |
40,624,435 |
40,739,692 |
RGD:6480464 |
CTD |
| G |
Vps33b |
vacuolar protein sorting 33 homolog B (yeast) |
|
increases expression |
ISO |
1 |
136,085,931 |
136,109,421 |
RGD:6480464 |
CTD |
| G |
Wdr13 |
WD repeat domain 13 |
|
decreases expression |
ISO |
X |
26,394,400 |
26,402,277 |
RGD:6480464 |
CTD |
| G |
Wdr46 |
WD repeat domain 46 |
|
decreases expression |
ISO |
20 |
5,089,611 |
5,097,383 |
RGD:6480464 |
CTD |
| G |
Wipf2 |
WAS/WASL interacting protein family, member 2 |
|
increases expression |
ISO |
10 |
87,660,351 |
87,676,889 |
RGD:6480464 |
CTD |
| G |
Wnk2 |
WNK lysine deficient protein kinase 2 |
|
decreases expression |
ISO |
17 |
21,461,980 |
21,600,361 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
increases expression |
EXP |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Zdhhc14 |
zinc finger, DHHC-type containing 14 |
|
decreases expression |
ISO |
1 |
40,474,618 |
40,701,834 |
RGD:6480464 |
CTD |
| G |
Zfp36 |
zinc finger protein 36 |
|
increases expression |
ISO |
1 |
83,486,643 |
83,489,123 |
RGD:6480464 |
CTD |
| G |
Zfp764 |
zinc finger protein 764 |
|
increases expression |
ISO |
1 |
186,648,287 |
186,650,295 |
RGD:6480464 |
CTD |
Term paths to the root
|